1. Home
  2. IMNN vs PC Comparison

IMNN vs PC Comparison

Compare IMNN & PC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • PC
  • Stock Information
  • Founded
  • IMNN 1982
  • PC 2012
  • Country
  • IMNN United States
  • PC Singapore
  • Employees
  • IMNN N/A
  • PC N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • PC Restaurants
  • Sector
  • IMNN Health Care
  • PC Consumer Discretionary
  • Exchange
  • IMNN Nasdaq
  • PC Nasdaq
  • Market Cap
  • IMNN 12.1M
  • PC 11.7M
  • IPO Year
  • IMNN 1985
  • PC 2024
  • Fundamental
  • Price
  • IMNN $6.53
  • PC $6.58
  • Analyst Decision
  • IMNN Buy
  • PC
  • Analyst Count
  • IMNN 2
  • PC 0
  • Target Price
  • IMNN $182.61
  • PC N/A
  • AVG Volume (30 Days)
  • IMNN 244.8K
  • PC 156.6K
  • Earning Date
  • IMNN 08-05-2025
  • PC 01-01-0001
  • Dividend Yield
  • IMNN N/A
  • PC N/A
  • EPS Growth
  • IMNN N/A
  • PC N/A
  • EPS
  • IMNN N/A
  • PC N/A
  • Revenue
  • IMNN N/A
  • PC $3,345,964.00
  • Revenue This Year
  • IMNN N/A
  • PC N/A
  • Revenue Next Year
  • IMNN N/A
  • PC N/A
  • P/E Ratio
  • IMNN N/A
  • PC N/A
  • Revenue Growth
  • IMNN N/A
  • PC N/A
  • 52 Week Low
  • IMNN $4.83
  • PC $5.11
  • 52 Week High
  • IMNN $41.22
  • PC $51.57
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 40.89
  • PC 48.27
  • Support Level
  • IMNN $6.17
  • PC $6.18
  • Resistance Level
  • IMNN $7.21
  • PC $7.55
  • Average True Range (ATR)
  • IMNN 0.51
  • PC 0.73
  • MACD
  • IMNN 0.14
  • PC -0.05
  • Stochastic Oscillator
  • IMNN 20.45
  • PC 37.68

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About PC Premium Catering (Holdings) Limited Ordinary Shares

Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. Are specialized in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume. Are an ACRA registered company and licensed by SFA to operate and process food business. Serve highquality value-packed food, company deliver's a reliable and dependable service to meet customer's daily meal requirements. The Company recognizes revenue from sales of budgeted prepared meals.

Share on Social Networks: